Z-1893-2020 Class III Terminated

Recalled by Abbott Laboratories — Abbott Park, IL

FDA device recall Z-1893-2020 was initiated by Abbott Laboratories on Apr 1, 2020 and is designated Class III. Reason for recall: Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained. The recall status is terminated (terminated Sep 1, 2020). Affected quantity: 65 kits total.

Recall details

Product Type
Devices
Report Date
May 13, 2020
Initiation Date
Apr 1, 2020
Termination Date
Sep 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
65 kits total

Product description

ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.

Reason for recall

Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained.

Distribution pattern

International distributed only in Mexico, no US distribution.

Code information

Lot Numbers 01719F000 (Exp Date 14MAY2020), 02519E000 (Exp Date 09APR2020)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1893-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1893-2020. Report a data issue: hello@regdatalab.com.